blood dyscrasia 血液恶病质 ; 血性恶液质
The research of the mechanism involves in biochemistry, molecular biology and blood dyscrasia, but it's center still is high blood sugar which causes a series changes of ischemia and hypoxia.
发病机制的研究涉及生物化学、分子生物学、血液异常的等方面，但其中心环节是高血糖和其引起组织缺血缺氧发生的一系列改变。
Etanercept should be discontinued if a blood dyscrasia is evident.
如果发生明显的血液恶液质，依那西普应当被停用。
It was found that this method of treatment is especially indicated in patients with blood dyscrasia with a clinical effective rate of 84.8%.
结果表明此疗法对合并有出血疾病的患者更适宜，临床治疗有效率为84.8%。
应用推荐